These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 8547236

  • 1. Identification of tyrosine 489 in the carboxy terminus of the Tpr-Met oncoprotein as a major site of autophosphorylation.
    Kamikura DM, Naujokas MA, Park M.
    Biochemistry; 1996 Jan 23; 35(3):1010-7. PubMed ID: 8547236
    [Abstract] [Full Text] [Related]

  • 2. Efficient cell transformation by the Tpr-Met oncoprotein is dependent upon tyrosine 489 in the carboxy-terminus.
    Fixman ED, Naujokas MA, Rodrigues GA, Moran MF, Park M.
    Oncogene; 1995 Jan 19; 10(2):237-49. PubMed ID: 7838524
    [Abstract] [Full Text] [Related]

  • 3. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
    Rodrigues GA, Park M.
    Oncogene; 1994 Jul 19; 9(7):2019-27. PubMed ID: 8208547
    [Abstract] [Full Text] [Related]

  • 4. Structural and functional domains critical for constitutive activation of the HGF-receptor (Met).
    Zhen Z, Giordano S, Longati P, Medico E, Campiglio M, Comoglio PM.
    Oncogene; 1994 Jun 19; 9(6):1691-7. PubMed ID: 8183564
    [Abstract] [Full Text] [Related]

  • 5. Receptor chimeras indicate that the met tyrosine kinase mediates the motility and morphogenic responses of hepatocyte growth/scatter factor.
    Zhu H, Naujokas MA, Park M.
    Cell Growth Differ; 1994 Apr 19; 5(4):359-66. PubMed ID: 8043510
    [Abstract] [Full Text] [Related]

  • 6. Tyrosines1234-1235 are critical for activation of the tyrosine kinase encoded by the MET proto-oncogene (HGF receptor).
    Longati P, Bardelli A, Ponzetto C, Naldini L, Comoglio PM.
    Oncogene; 1994 Jan 19; 9(1):49-57. PubMed ID: 8302603
    [Abstract] [Full Text] [Related]

  • 7. A novel small molecule met inhibitor induces apoptosis in cells transformed by the oncogenic TPR-MET tyrosine kinase.
    Sattler M, Pride YB, Ma P, Gramlich JL, Chu SC, Quinnan LA, Shirazian S, Liang C, Podar K, Christensen JG, Salgia R.
    Cancer Res; 2003 Sep 01; 63(17):5462-9. PubMed ID: 14500382
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene.
    Vigna E, Naldini L, Tamagnone L, Longati P, Bardelli A, Maina F, Ponzetto C, Comoglio PM.
    Cell Mol Biol (Noisy-le-grand); 1994 Jul 01; 40(5):597-604. PubMed ID: 7981617
    [Abstract] [Full Text] [Related]

  • 9. Use of signal specific receptor tyrosine kinase oncoproteins reveals that pathways downstream from Grb2 or Shc are sufficient for cell transformation and metastasis.
    Saucier C, Papavasiliou V, Palazzo A, Naujokas MA, Kremer R, Park M.
    Oncogene; 2002 Mar 14; 21(12):1800-11. PubMed ID: 11896612
    [Abstract] [Full Text] [Related]

  • 10. Regulation of the urokinase-type plasminogen activator gene by the oncogene Tpr-Met involves GRB2.
    Besser D, Bardelli A, Didichenko S, Thelen M, Comoglio PM, Ponzetto C, Nagamine Y.
    Oncogene; 1997 Feb 13; 14(6):705-11. PubMed ID: 9038378
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of junction assembly in cultured epithelial cells by hepatocyte growth factor/scatter factor is concomitant with increased stability and altered phosphorylation of the soluble junctional molecules.
    Pasdar M, Li Z, Marreli M, Nguyen BT, Park M, Wong K.
    Cell Growth Differ; 1997 Apr 13; 8(4):451-62. PubMed ID: 9101091
    [Abstract] [Full Text] [Related]

  • 12. Hepatocyte growth factor/scatter factor activates the ETS1 transcription factor by a RAS-RAF-MEK-ERK signaling pathway.
    Paumelle R, Tulasne D, Kherrouche Z, Plaza S, Leroy C, Reveneau S, Vandenbunder B, Fafeur V.
    Oncogene; 2002 Apr 04; 21(15):2309-19. PubMed ID: 11948414
    [Abstract] [Full Text] [Related]

  • 13. Regulation of the wild-type and Y1235D mutant Met kinase activation.
    Cristiani C, Rusconi L, Perego R, Schiering N, Kalisz HM, Knapp S, Isacchi A.
    Biochemistry; 2005 Nov 01; 44(43):14110-9. PubMed ID: 16245927
    [Abstract] [Full Text] [Related]

  • 14. [Analysis of the hepatocyte growth factor receptor in regeneration and oncogenesis of hepatocytes].
    Annen K.
    Hokkaido Igaku Zasshi; 1994 Mar 01; 69(2):301-11. PubMed ID: 8157255
    [Abstract] [Full Text] [Related]

  • 15. A juxtamembrane autophosphorylation site in the Eph family receptor tyrosine kinase, Sek, mediates high affinity interaction with p59fyn.
    Ellis C, Kasmi F, Ganju P, Walls E, Panayotou G, Reith AD.
    Oncogene; 1996 Apr 18; 12(8):1727-36. PubMed ID: 8622893
    [Abstract] [Full Text] [Related]

  • 16. Oligomerization-induced differential dephosphorylation of c-Met receptor tyrosine kinase.
    Sheth PR, Watowich SJ.
    Biochemistry; 2005 Aug 23; 44(33):10984-93. PubMed ID: 16101282
    [Abstract] [Full Text] [Related]

  • 17. Signaling requirements for oncogenic forms of the Met tyrosine kinase receptor.
    Jeffers M, Koochekpour S, Fiscella M, Sathyanarayana BK, Vande Woude GF.
    Oncogene; 1998 Nov 26; 17(21):2691-700. PubMed ID: 9840933
    [Abstract] [Full Text] [Related]

  • 18. Activation of the JNK pathway is essential for transformation by the Met oncogene.
    Rodrigues GA, Park M, Schlessinger J.
    EMBO J; 1997 May 15; 16(10):2634-45. PubMed ID: 9184210
    [Abstract] [Full Text] [Related]

  • 19. Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET.
    Vigna E, Gramaglia D, Longati P, Bardelli A, Comoglio PM.
    Oncogene; 1999 Jul 22; 18(29):4275-81. PubMed ID: 10435641
    [Abstract] [Full Text] [Related]

  • 20. The human met oncogene is a member of the tyrosine kinase family.
    Gonzatti-Haces M, Park M, Dean M, Blair DG, Vande Woude GF.
    Princess Takamatsu Symp; 1986 Jul 22; 17():221-32. PubMed ID: 3332011
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.